Worldwide Nuclear Medicine Radioisotopes Market Research Report 2021 by Type, Application, Participants and Countries, COVID-19 Impact, Forecast Year to 2026
- Report Code : PW 2535546
- Published On: Jun, 2021
- Category : Pharmaceuticals
- Pages : 140
-
Due to the high popularity of this product/service in North America and Asia, the growth trend of Nuclear Medicine Radioisotopes in recent years and the growth of consumers' demand is expected to drive the global Nuclear Medicine Radioisotopes market.
Geographically, the global Nuclear Medicine Radioisotopes market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.
North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Nuclear Medicine Radioisotopes market in North America.
Significant participants active in the global Nuclear Medicine Radioisotopes market include: Agfa-Gevaert N.V., Cardinal Health Inc., Medx Inc, Cardiarc Ltd, Nordion (Canada) Inc., Segami Corporation, NTP Radioisotopes SOC Ltd, Digirad Corporation, Gamma Medica Inc, CMR Naviscan (Gamma Medica Inc.), Hologic Inc., Ge Healthcare, Positron Corporation, Bracco S.p.A, Curium, Siemens Healthcare, Naviscan Inc
Global Nuclear Medicine Radioisotopes Market Segmentation:
Nuclear Medicine Radioisotopes market, by Nuclear Medicine Radioisotopes type:
Rubidium-82 (Rb-82)
Actinium-225 (Ac-225)
Radium-223 (Ra-223) & Alpharadin
Technetium-99m (Tc-99m)
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Iodine-131 (I-131)
Lutetium-177 (Lu-177)
Others
…
Nuclear Medicine Radioisotopes market, by Application:
Oncology
Cardiology
Lymphoma
Thyroid
Neurology
Others
…
Nuclear Medicine Radioisotopes Market Research Report 2014-2026, by region:
North America
The U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Pan Asia Pacific
China
Japan
South Korea
South East Asia Region
India
Australia
Middle East and Africa
Saudi Arabia
UAE
Qatar
Egypt
Nigeria
South Africa
Rest of MEA
The database is running updated by a group of research experts to always reflect the latest trends and information.
-
With tables and figures helping analyze worldwide Nuclear Medicine Radioisotopes market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1. Introduction1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Nuclear Medicine Radioisotopes by Different End-User/Applications3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Nuclear Medicine Radioisotopes Market-Segmentation4.1 By Type
4.1.1 Rubidium-82 (Rb-82)
4.1.2 Actinium-225 (Ac-225)
4.1.3 Radium-223 (Ra-223) & Alpharadin
4.1.4 Technetium-99m (Tc-99m)
4.1.5 Thallium-201 (Tl-201)
4.1.6 Iodine (I-123)
4.1.7 Fluorine-18
4.1.8 Iodine-131 (I-131)
4.1.9 Lutetium-177 (Lu-177)
4.1.10 Others4.2 By End-User/Application Industry
4.2.1 Oncology
4.2.2 Cardiology
4.2.3 Lymphoma
4.2.4 Thyroid
4.2.5 Neurology
4.2.6 Others4.3 By Geography
4.3.1 North America Nuclear Medicine Radioisotopes Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Nuclear Medicine Radioisotopes Production from 2014-2020
4.3.1.2 North America Nuclear Medicine Radioisotopes Consumption from 2014-2020
4.3.1.3 North America Nuclear Medicine Radioisotopes Import and Export from 2014-2020
4.3.1.4 North America Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Nuclear Medicine Radioisotopes Participants Value ($) and Market Share (%) in 2019
4.3.2 Europe Nuclear Medicine Radioisotopes Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Nuclear Medicine Radioisotopes Production from 2014-2020
4.3.2.2 Europe Nuclear Medicine Radioisotopes Consumption from 2014-2020
4.3.2.3 Europe Nuclear Medicine Radioisotopes Import and Export from 2014-2020
4.3.2.4 Europe Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Nuclear Medicine Radioisotopes Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Nuclear Medicine Radioisotopes Participants Value ($) and Market Share (%) in 2019
4.3.3 Asia-Pacific Nuclear Medicine Radioisotopes Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Nuclear Medicine Radioisotopes Production from 2014-2020
4.3.3.2 Asia-Pacific Nuclear Medicine Radioisotopes Consumption from 2014-2020
4.3.3.3 Asia-Pacific Nuclear Medicine Radioisotopes Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Nuclear Medicine Radioisotopes Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Nuclear Medicine Radioisotopes Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Nuclear Medicine Radioisotopes Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Nuclear Medicine Radioisotopes Participants Value ($) and Market Share (%) in 2019
4.3.4 Latin America Nuclear Medicine Radioisotopes Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Nuclear Medicine Radioisotopes Production from 2014-2020
4.3.4.2 Latin America Nuclear Medicine Radioisotopes Consumption from 2014-2020
4.3.4.3 Latin America Nuclear Medicine Radioisotopes Import and Export from 2014-2020
4.3.4.4 Latin America Nuclear Medicine Radioisotopes Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Nuclear Medicine Radioisotopes Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Nuclear Medicine Radioisotopes Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Nuclear Medicine Radioisotopes Participants Value ($) and Market Share (%) in 2019
4.3.5 Middle East & Africa Nuclear Medicine Radioisotopes Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Nuclear Medicine Radioisotopes Production from 2014-2020
4.3.5.2 Middle East & Africa Nuclear Medicine Radioisotopes Consumption from 2014-2020
4.3.5.3 Middle East & Africa Nuclear Medicine Radioisotopes Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Nuclear Medicine Radioisotopes Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Nuclear Medicine Radioisotopes Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Nuclear Medicine Radioisotopes Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Nuclear Medicine Radioisotopes Participants Value ($) and Market Share (%) in 2019
5. Competitive Intelligence – Company Profiles5.1 Agfa-Gevaert N.V.
5.1.1 Agfa-Gevaert N.V. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Agfa-Gevaert N.V. Sales, Growth Rate and Global Market Share from 2014-20205.2 Cardinal Health Inc.
5.2.1 Cardinal Health Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Cardinal Health Inc. Sales, Growth Rate and Global Market Share from 2014-20205.3 Medx Inc
5.3.1 Medx Inc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Medx Inc Sales, Growth Rate and Global Market Share from 2014-20205.4 Cardiarc Ltd
5.4.1 Cardiarc Ltd Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Cardiarc Ltd Sales, Growth Rate and Global Market Share from 2014-20205.5 Nordion (Canada) Inc.
5.5.1 Nordion (Canada) Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Nordion (Canada) Inc. Sales, Growth Rate and Global Market Share from 2014-20205.6 Segami Corporation
5.6.1 Segami Corporation Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Segami Corporation Sales, Growth Rate and Global Market Share from 2014-2020
5.7 NTP Radioisotopes SOC Ltd
5.7.1 NTP Radioisotopes SOC Ltd Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 NTP Radioisotopes SOC Ltd Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Digirad Corporation
5.8.1 Digirad Corporation Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Digirad Corporation Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Gamma Medica Inc
5.9.1 Gamma Medica Inc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Gamma Medica Inc Sales, Growth Rate and Global Market Share from 2014-20205.10 CMR Naviscan (Gamma Medica Inc.)
5.10.1 CMR Naviscan (Gamma Medica Inc.) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 CMR Naviscan (Gamma Medica Inc.) Sales, Growth Rate and Global Market Share from 2014-2020
5.11 Hologic Inc.
5.11.1 Hologic Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.11.2 Hologic Inc. Sales, Growth Rate and Global Market Share from 2014-2020
5.12 Ge Healthcare
5.12.1 Ge Healthcare Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.12.2 Ge Healthcare Sales, Growth Rate and Global Market Share from 2014-2020
5.13 Positron Corporation
5.13.1 Positron Corporation Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.13.2 Positron Corporation Sales, Growth Rate and Global Market Share from 2014-2020
5.14 Bracco S.p.A
5.14.1 Bracco S.p.A Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.14.2 Bracco S.p.A Sales, Growth Rate and Global Market Share from 2014-2020
5.15 Curium
5.15.1 Curium Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.15.2 Curium Sales, Growth Rate and Global Market Share from 2014-2020
5.16 Siemens Healthcare
5.16.1 Siemens Healthcare Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.16.2 Siemens Healthcare Sales, Growth Rate and Global Market Share from 2014-2020
5.17 Naviscan Inc
5.17.1 Naviscan Inc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.17.2 Naviscan Inc Sales, Growth Rate and Global Market Share from 2014-2020
6. Investment Analysis6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of the Global Nuclear Medicine Radioisotopes Market from 2021-20267.1 Future Forecast of Global Nuclear Medicine Radioisotopes Market from 2021-2026 Segment by Region
7.2 Future Forecast of the Global Nuclear Medicine Radioisotopes Market from 2021-2026 Segment by Types
7.3 Future Forecast of the Global Nuclear Medicine Radioisotopes Market from 2021-2026 Segment by End-User/Applications
8 Appendix8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
9 Disclaimer
-
The Nuclear Medicine Radioisotopes Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
New players are entering the Nuclear Medicine Radioisotopes Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
The Nuclear Medicine Radioisotopes Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.
Consumer behavior changes will reshape the entire decision-making process and companies in the Nuclear Medicine Radioisotopes Industry will need to adapt quickly.
Companies in the Nuclear Medicine Radioisotopes Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the Nuclear Medicine Radioisotopes Market's trajectory and future outlook.
